Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$743K Sell
7,660
-2,000
-21% -$204K 0.05% 112
2022
Q2
$902K Hold
9,660
0.06% 107
2022
Q1
$1.03M Sell
9,660
-1,400
-13% -$136K 0.04% 110
2021
Q4
$1.23M Buy
11,060
+800
+8% +$86.2K 0.04% 96
2021
Q3
$976K Buy
10,260
+6,552
+177% +$641K 0.04% 117
2021
Q2
$354K Buy
3,708
+48
+1% +$4.25K 0.01% 287
2021
Q1
$312K Hold
3,660
0.01% 300
2020
Q4
$323K Sell
3,660
-336
-8% -$29.2K 0.01% 266
2020
Q3
$332K Sell
3,996
-327,052
-99% -$25.2M 0.02% 229
2020
Q2
$22M Buy
331,048
+164,144
+98% +$9.49M 1.24% 26
2020
Q1
$7.23M Buy
+166,904
New +$10.9M 0.62% 35
2018
Q2
Sell
-52,800
Closed -$2.25M 314
2018
Q1
$2.25M Buy
+52,800
New +$2.19M 0.12% 53

Other funds holding CTAS

R.H. Bluestein & Co's CTAS Position: Q3 2022 in Review

R.H. Bluestein & Co reduced its Cintas (CTAS) stake by 21% in Q3 2022, selling an estimated $204K and leaving 7,660 shares worth $743K. The position accounts for 0.05% of the portfolio, ranked #112.

R.H. Bluestein & Co first reported a position in CTAS in Q1 2018 and has held it in 12 quarters since. The position peaked at $22M in Q2 2020. 920 funds tracked by Wall St. Rank hold CTAS as of Q3 2022.

  • R.H. Bluestein & Co held 7,660 shares of Cintas worth $743K as of Q3 2022.
  • R.H. Bluestein & Co sold 2,000 Cintas shares in Q3 2022, an estimated $204K.
  • Cintas made up 0.05% of R.H. Bluestein & Co's portfolio in Q3 2022, its #112 holding.
  • R.H. Bluestein & Co first reported a position in Cintas in Q1 2018 and has held it in 12 quarters since.
  • R.H. Bluestein & Co's Cintas position peaked at $22M in Q2 2020.
  • 920 funds tracked by Wall St. Rank held Cintas as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.